Oragenics, Inc.
OGEN
$0.50
-$0.01-2.27%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.86M | 6.11M | 8.40M | 11.40M | 1.97M |
| Total Receivables | -- | -- | 53.10K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.63M | 1.38M | 1.62M | 1.30M | 166.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.49M | 7.49M | 10.07M | 12.71M | 2.14M |
|
|
|||||
| Total Current Assets | 5.49M | 7.49M | 10.07M | 12.71M | 2.14M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 5.49M | 7.49M | 10.07M | 12.71M | 2.14M |
|
|
|||||
| Total Accounts Payable | 1.82M | 1.25M | 1.56M | 1.78M | 1.27M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 56.10K | 227.30K | 394.80K | 3.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 700.00K | -- |
| Total Other Current Liabilities | -- | -- | -- | 700.00K | -- |
| Total Current Liabilities | 1.82M | 1.31M | 1.79M | 2.87M | 4.27M |
|
|
|||||
| Total Current Liabilities | 1.82M | 1.31M | 1.79M | 2.87M | 4.27M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 56.10K | 227.30K | 394.80K | 3.00M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.82M | 1.31M | 1.79M | 2.87M | 4.27M |
|
|
|||||
| Common Stock & APIC | 235.03M | 235.01M | 234.91M | 234.17M | 219.15M |
| Retained Earnings | -231.36M | -228.83M | -226.63M | -224.34M | -221.28M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.67M | 6.18M | 8.28M | 9.83M | -2.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.67M | 6.18M | 8.28M | 9.83M | -2.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.67M | 6.18M | 8.28M | 9.83M | -2.13M |
|
|
|||||